Press Releases

    • April 1, 2020

    Nemaura Plans To Launch Body-Worn Continuous Temperature Monitor (CTM) to Track Fever Caused by Viral Infections such as COVID-19

    BEAT® platform is planned to be extended to conditions requiring continuous temperature monitoring including viral infections and poor blood...

    Read more
    March 30, 2020

    Nemaura to launch new digital brand proBEAT™ in the USA, Targeting a Market of over 100 Million potential users with its Prescription-Free Consumer Wellness Glucose Monitoring Device and Digital Healthcare Subscription Service

      Loughborough, England, March 30, 2020 — Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology...

    Read more
    March 10, 2020

    Nemaura Medical enters into multiple verbal non-binding agreements for its sugarBEAT® platform

    sugarBEAT® strategic global partnership(s) a step closer as Nemaura Medical enters into multiple verbal non-binding agreements Loughborough, England, March...

    Read more
    March 3, 2020

    Nemaura Medical Launches sugarBEAT® App on Play Store Ahead of its Planned Commercial Launch of BEAT®diabetes Subscription Service

    sugarBEAT® App is now available on Play Store with iOS app planned to follow, ahead of the planned BEAT®diabetes...

    Read more
    February 25, 2020

    Nemaura Medical Plans Head-to-Head Study with Major Glucose Monitoring System

    Studies planned to compare sugarBEAT® and major continuous glucose monitor sensor, seeking to position sugarBEAT® as both a possible...

    Read more
    February 11, 2020

    Nemaura Medical Reports Results and Provides Business Update for the Third Quarter Ended December 31, 2019

    Loughborough, England, Feb. 11, 2020 (GLOBE NEWSWIRE) — – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company...

    Read more
    December 20, 2019

    Nemaura Provides 2019 Year-End Corporate Update

    Loughborough, England, Dec. 20, 2019 (GLOBE NEWSWIRE) —  Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company commercializing sugarBEAT®,...

    Read more
    December 5, 2019

    Nemaura Medical announces expansion of SugarBEAT® offering with BEAT® Diabetes digital subscription services

    BEAT® Diabetes utilizes SugarBEAT® CGM data to provide holistic coaching services via user-friendly app to enhance outcomes for diabetic...

    Read more
    December 4, 2019

    Nemaura Medical Announces 1 for 10 Reverse Split Intended to Attract a Wider Universe of Institutional Investors

    Loughborough, England, Dec. 04, 2019 (GLOBE NEWSWIRE) —  Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused...

    Read more
    November 11, 2019

    Nemaura Medical Reports Results and Provides Business Update for the Second Quarter Ended September 30, 2019

    Loughborough, England, Nov. 11, 2019 (GLOBE NEWSWIRE) —  – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company...

    Read more